Eli Lilly’s stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring ...

Drugmaker Eli Lilly on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case ...

Baron Funds mentioned Eli Lilly and Company (NYSE:LLY) in its Q2 2024 investor letter. Here is what the fund said: ...

Groundbreaking for the Limerick site took place in March 2023, with production expected to commence in 2026. The September 13, 2024 announcement of the additional investment signifies Eli Lilly's ...

"Eli Lilly to invest $1.8bn in manufacturing capacity in Ireland" was originally created and published by Pharmaceutical ...

Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular obesity drug and a newly approved treatment for Alzheimer's, the drugmaker said ...

Eli Lilly and Company (NYSE:LLY) on Thursday announced a $1.8 billion investment to expand its manufacturing operations in ...

Eli Lilly (NYSE: LLY) stands atop the biopharmaceutical world. It's the biggest drugmaker by far based on market cap. Lilly's share price has skyrocketed nearly 700% over the last five years and ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... unless you really love your job. I’m betting most of you, even if you don’t own individual stocks, still ...

A pair of late-stage trials found that Eli Lilly & Co.’s experimental once-weekly insulin can lower blood sugar as effectively as widely used daily insulins, the drugmaker said Thursday ...

Positive late-stage trial results come after Novo Nordisk's weekly insulin was rejected by FDA A pair of late-stage trials found that Eli Lilly & Co.'s experimental once-weekly insulin can lower ...

Eli Lilly (NYSE:LLY) announced on Wednesday an agreement with Egypt-based EVA Pharma to license certain manufacturing know-how related to its JAK inhibitor Olumiant (baricitinib) for Africa.